Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.

Tapashi DalviMette NørgaardJon P FryzekNaimisha MovvaLars PedersenHanh Pham HansenJill WalkerAnita MidhaNorah ShireAnne-Marie BoothmanJames RigasAnders MellemgaardTorben R RasmussenStephen Jacques Hamilton-DutoitDeirdre Cronin-Fenton

Published in: PloS one (2023)

A prognostic impact for NSCLC patients receiving adjuvant chemotherapy was not associated with PD-L1 expression, or with EGFR and KRAS mutations.

Keyphrases

small cell lung cancer
poor prognosis
epidermal growth factor receptor
advanced non small cell lung cancer
tyrosine kinase
brain metastases
binding protein
wild type
long non coding rna